Strs Ohio cut its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 13.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 101,633 shares of the real estate investment trust’s stock after selling 16,237 shares during the period. Strs Ohio’s holdings in Sabra Healthcare REIT were worth $2,449,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Municipal Employees Retirement System of Michigan increased its position in Sabra Healthcare REIT by 1.0% in the first quarter. Municipal Employees Retirement System of Michigan now owns 14,910 shares of the real estate investment trust’s stock valued at $416,000 after buying an additional 150 shares during the last quarter. AQR Capital Management LLC increased its position in Sabra Healthcare REIT by 0.4% in the fourth quarter. AQR Capital Management LLC now owns 42,382 shares of the real estate investment trust’s stock valued at $1,035,000 after buying an additional 171 shares during the last quarter. Blair William & Co. IL increased its position in Sabra Healthcare REIT by 0.9% in the first quarter. Blair William & Co. IL now owns 27,568 shares of the real estate investment trust’s stock valued at $770,000 after buying an additional 250 shares during the last quarter. Albert D Mason Inc. increased its position in Sabra Healthcare REIT by 1.1% in the first quarter. Albert D Mason Inc. now owns 29,595 shares of the real estate investment trust’s stock valued at $827,000 after buying an additional 315 shares during the last quarter. Finally, Louisiana State Employees Retirement System increased its position in Sabra Healthcare REIT by 1.5% in the first quarter. Louisiana State Employees Retirement System now owns 26,600 shares of the real estate investment trust’s stock valued at $743,000 after buying an additional 400 shares during the last quarter. Institutional investors and hedge funds own 99.26% of the company’s stock.

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) opened at 22.19 on Thursday. The stock has a market cap of $1.45 billion, a P/E ratio of 18.68 and a beta of 0.89. The firm’s 50 day moving average price is $23.53 and its 200 day moving average price is $25.35. Sabra Healthcare REIT, Inc. has a 52-week low of $19.30 and a 52-week high of $29.10.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Monday, May 8th. The real estate investment trust reported $0.25 EPS for the quarter, missing the consensus estimate of $0.58 by $0.33. The company had revenue of $62.65 million during the quarter, compared to analysts’ expectations of $63.47 million. Sabra Healthcare REIT had a return on equity of 8.72% and a net margin of 34.99%. The firm’s revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.54 EPS. On average, analysts expect that Sabra Healthcare REIT, Inc. will post $1.18 EPS for the current year.

The business also recently declared a dividend, which will be paid on Friday, August 18th. Shareholders of record on Wednesday, August 16th will be paid a $0.3599 dividend. The ex-dividend date of this dividend is Monday, August 14th. Sabra Healthcare REIT’s payout ratio is currently 145.76%.

TRADEMARK VIOLATION NOTICE: “Sabra Healthcare REIT, Inc. (SBRA) Shares Sold by Strs Ohio” was published by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this story can be read at https://www.watchlistnews.com/sabra-healthcare-reit-inc-sbra-shares-sold-by-strs-ohio/1467027.html.

Several research firms recently commented on SBRA. Mizuho downgraded Sabra Healthcare REIT from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $25.00 to $23.00 in a research note on Monday, July 10th. Zacks Investment Research upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Wednesday. BidaskClub upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. Canaccord Genuity reiterated a “hold” rating and issued a $26.00 price objective on shares of Sabra Healthcare REIT in a research note on Tuesday, May 9th. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $26.00 price objective on shares of Sabra Healthcare REIT in a research note on Friday, July 28th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $26.57.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA).

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.